A dual-action GIP/GLP-1 therapy — prescribed by a licensed provider, compounded for you at a US-licensed 503A pharmacy, and shipped directly to your door.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — it acts on two metabolic hormone pathways rather than one. It's the active ingredient in the FDA-approved brand medications Mounjaro® and Zepbound®.
Compounded tirzepatide is prepared by a licensed compounding pharmacy specifically for you, pursuant to a prescription from a licensed provider — a legitimate clinical path to one of the most advanced therapies in metabolic medicine.
Tirzepatide activates both GIP and GLP-1 receptors — two complementary hormone systems involved in appetite and metabolic regulation.
Like GLP-1 therapies, it supports reduced hunger and prolonged fullness by acting on appetite-regulation centers and slowing gastric emptying.
The combined receptor activity plays a role in how the body handles blood sugar and insulin response, supporting overall metabolic health.
1. Online consult — complete your health intake and connect with a licensed provider. 2. Provider reviews — if treatment is appropriate for you, they write your prescription. 3. Compounded for you — a US-licensed 503A pharmacy prepares your medication in a cGMP facility. 4. Delivered — shipped from the pharmacy directly to your door.
Compounded tirzepatide is tirzepatide prepared by a licensed compounding pharmacy for an individual patient based on a valid prescription. It contains the same active ingredient found in brand dual GIP/GLP-1 medications, prepared specifically for you under pharmacist oversight.
Semaglutide acts on one hormone pathway (GLP-1). Tirzepatide acts on two (GIP and GLP-1). Which therapy is appropriate for you is a clinical decision your licensed provider makes based on your health history and goals.
Yes. Tirzepatide is a prescription medication. A licensed provider reviews your health intake and determines whether treatment is appropriate. If prescribed, your medication ships directly from a US-licensed pharmacy.
No. Compounded medications are not FDA-approved. They are prepared by licensed pharmacies for individual patients under federal and state regulations. We're direct about that — clarity is part of our standard.
If prescribed, your medication is compounded for you and typically ships within about a week, in cold-chain packaging where required.
Commonly reported side effects include nausea, digestive discomfort, and reduced appetite, particularly when starting therapy. Your licensed provider will review your health history and discuss whether tirzepatide is appropriate for you.
Quov is launching soon. Join the waitlist for early access and founding-member pricing on your first consult.
Join the waitlistTirzepatide is available only if a licensed healthcare provider determines, after a clinical evaluation, that treatment is appropriate for you. There is no guarantee you will be prescribed any particular treatment.
Compounded medications are prepared for an individual patient pursuant to a valid prescription and are not approved by the FDA. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. Brand names referenced are trademarks of their respective owners and are used for identification of active ingredients only; Quov is not affiliated with or endorsed by their manufacturers.
The information on this page is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider regarding your health.